Concord Biotech Limited — Others, 10-08-2025: Copy of Newspaper Publication

Concord Biotech Limited has released its financial results for the quarter ended June 30, 2025. The company posted a consolidated income from operations of ₹249.07 Cr, alongside a consolidated net profit after tax of ₹32.35 Cr. For its standalone operations, the income was ₹125.47 Cr, achieving a net profit after tax of ₹18.83 Cr. These figures offer shareholders a transparent view of the company's recent financial health and operational performance.